BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11909894)

  • 21. Role of levetiracetam in the treatment of epilepsy.
    Brodie MJ; French JA
    Epileptic Disord; 2003 May; 5 Suppl 1():S65-72. PubMed ID: 12915344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam use in pregnancy.
    Longo B; Forinash AB; Murphy JA
    Ann Pharmacother; 2009 Oct; 43(10):1692-5. PubMed ID: 19690219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction.
    Sisodiya SM; Sander JW; Patsalos PN
    Epilepsy Res; 2002 Feb; 48(3):217-9. PubMed ID: 11904240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levetiracetam: a novel antiepileptic drug.
    Hovinga CA
    Pharmacotherapy; 2001 Nov; 21(11):1375-88. PubMed ID: 11714211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spritam--a new formulation of levetiracetam for epilepsy.
    Med Lett Drugs Ther; 2016 Jun; 58(1497):78-9. PubMed ID: 27305068
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of levetiracetam on essential tremor.
    Bushara KO; Malik T; Exconde RE
    Neurology; 2005 Mar; 64(6):1078-80. PubMed ID: 15781835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuation rates of levetiracetam in children from the EULEVp cohort study.
    Dureau-Pournin C; Pédespan JM; Droz-Perroteau C; Lavernhe G; Mann M; Pollet C; Robinson P; Jové J; Moore N; Fourrier-Réglat A;
    Eur J Paediatr Neurol; 2014 Jan; 18(1):19-24. PubMed ID: 24035600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levetiracetam in the management of epilepsy.
    Leach JP
    Hosp Med; 2004 Dec; 65(12):740-4. PubMed ID: 15624450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Levetiracetam].
    Salas-Puig J; Calleja S
    Neurologia; 2001 Nov; 16(9):427-32. PubMed ID: 11742623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Issues in the treatment of epilepsy.
    Leppik IE
    Epilepsia; 2001; 42 Suppl 4():1-6. PubMed ID: 11564117
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
    Patsalos PN
    Pharmacol Ther; 2000 Feb; 85(2):77-85. PubMed ID: 10722121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of levetiracetam among infants younger than 12 months--Results from a European multicenter observational study.
    Arzimanoglou A; Lösch C; Garate P; Bentz J
    Eur J Paediatr Neurol; 2016 May; 20(3):368-75. PubMed ID: 26876768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis.
    Dudra-Jastrzebska M; Andres-Mach MM; Sielski M; Ratnaraj N; Patsalos PN; Czuczwar SJ; Luszczki JJ
    Eur J Pharmacol; 2009 Mar; 605(1-3):87-94. PubMed ID: 19168049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levetiracetam: a comprehensive review.
    Crepeau AZ; Treiman DM
    Expert Rev Neurother; 2010 Feb; 10(2):159-71. PubMed ID: 20136375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous subcutaneous use of levetiracetam: a retrospective review of tolerability and clinical effects.
    Rémi C; Lorenzl S; Vyhnalek B; Rastorfer K; Feddersen B
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):371-7. PubMed ID: 25313924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Probable levetiracetam-induced psychosis].
    Roig J; Carreño MM; Parellada E
    Med Clin (Barc); 2007 Jul; 129(7):278. PubMed ID: 17683712
    [No Abstract]   [Full Text] [Related]  

  • 37. A Review on Pharmacokinetics of Levetiracetam in Neonates.
    Agrawal A; Banergee A
    Curr Drug Metab; 2017 Oct; 18(8):727-734. PubMed ID: 28595534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can High-Dose Levetiracetam Be Safe? A Case Report of Prolonged Accidental High-Dose Levetiracetam Administration and Review of the Literature.
    Kartal A
    Clin Neuropharmacol; 2017; 40(5):217-218. PubMed ID: 28682928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
    Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
    Obeid M; Pong AW
    Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.